Apellis PharmaceuticalsAPLS

Apellis Pharmaceuticals

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Dr. Cedric Francois, M.D.

$4.6B

Market Cap • 18/07/2024

2009

(há 15 anos)
Fundação

2017

(7 years ago)
IPO

NASDAQ

Listagem
Flag of US

Waltham

Sede • Massachusetts

767

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

APLSSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-1%

1 dia

15/07/2024

5%

1 semana

10/07/2024

-2%

1 mês

17/06/2024

15%

1 ano

20/07/2023

46%

5 anos

17/07/2019

10 anos

Histórico